Midgard Science

DavosPharma

Upper Saddle River, NJ, United States davos.com

From their website, Nov 2026

Work here? Claim this listing

About

DavosPharma coordinates drug development outsourcing for biotech and pharmaceutical companies, with support across discovery, CMC, toxicology, and regulatory strategy. It works with a global network of vetted CROs, CDMOs, and consultants to help clients reach IND submission.

Services

  • Integrated IND Platform

    Manages a coordinated program from CMC and toxicology through regulatory strategy and vendor coordination for IND submission.

  • Discovery

    Coordinates hit-to-lead chemistry, ADME/PK, early biology, in vitro and in vivo pharmacology, and bioanalytical method development through vetted CROs.

    Assays & in vitro testing

  • Small Molecule

    Matches projects involving peptides, HPAPIs, controlled substances, and complex chemistries with CDMOs for process development, scale-up, and manufacturing.

  • Biologics

    Matches biologics programs with CDMOs for analytical development, potency testing, validation, and manufacturing of modalities such as antibodies, gene therapies, RNA-based platforms, vaccines, enzymes, and biosimilars.

  • Drug Product

    Coordinates formulation development, preformulation assessment, tech transfer, validation support, and GMP manufacturing for drug products from capsules to injectables.

  • Toxicology

    Coordinates GLP-compliant toxicology studies, including acute, subchronic, chronic, reproductive and DART, safety pharmacology, and genotoxicity work.

    ADME, DMPK & toxicology

Turnaround
3x faster average CRO onboarding time · 10-12 months average time from lab scale familiarization to delivery of Phase 1 API · 3x faster average CRO onboarding time compared to teams managing vendor outreach alone · 10-12 months our average time from lab scale familiarization to delivery of Phase 1 API

Capabilities

Assays and studies
Small molecules · Toxicology · Peptides · ADME · Antibodies · Fill-finish · Bioanalysis · In vivo · Analytical development · Hit-to-lead · ADME/PK · Early biology
17 moreIn vitro pharmacology · In vivo pharmacology · Bioanalytical method development · Custom assay development · Potency testing · Analytical validation · Preformulation assessment · Acute toxicity · Subchronic toxicity · Chronic toxicity · Reproductive toxicity · Developmental toxicity (DART) · Hit-to-lead chemistry · Early biology studies · Developmental toxicity · Safety pharmacology · Genotoxicity
Scale and capacity
Over 100 vetted CDMOs and CROs in the network · 80+ INDs filed to date

Modalities and species

Modalities
Small molecule · Antibody · Bispecific · ADC · Peptide · Oligonucleotide · mRNA · Viral vector · Cell therapy · Vaccine · Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    Scope: toxicology studies

  • GMPSelf-reported

    Scope: drug product manufacturing and vetted manufacturing partners

Industries served

  • Biotech
  • Pharmaceutical
  • Academic
  • Industry

Company

Type
CRDMO
Founded
1972

Locations

Address
600 E Crescent Ave, Upper Saddle River, NJ 07458, United States
Sites
Upper Saddle River, United States
Serves
North America, Europe, Asia, global

Contacts

Public records

Biocom California CRO directory
clinical trials, Custom Chemistry, Drug Product, Preclinical Research, process development source

Similar labs

Work here? Claim this listing